ADMA Biologics Addresses Misleading Short-Seller Report
ADMA Biologics, a U.S.-based biopharmaceutical company specializing in plasma-derived biologics for immune deficiencies, has publicly addressed a negative short-seller report issued by Culper Research. The company refutes the report's assertions as speculative and false, emphasizing its compliance with regulatory standards and ongoing review of the…